Skip to main content
Kane Biotech
Biofilms
Biofilm R+D
Understanding Biofilms
Biofilm – Problem Areas
Our Facilities
Glossary of Terms
Sources
Technologies
Human Health
Animal Health
Industrial
About
About Us
Our Team
Awards
Careers
Investors
Overview
News / Events
Company Information
Financial Results
Stock Data
SEDAR
Corporate Governance
Contact
Press Releases
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.
Investors
Overview
News / Events
Press Releases
IR Calendar
Email Alerts
Company Info
Profile
2019 Business Update Video
Presentations
Management Team
Contacts
Financial Results
Stock Data
TSX-V:KNE
OTCPink:KNBIF
SEDAR
Governance
Board of Directors
Board Committees
Governance Documents
Investor Tools
Email Alerts
Tear Sheet
Contacts
RSS News Feed
News / Events
Press Releases
IR Calendar
Email Alerts
All News
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
DispersinB(R) Wound Spray Passes Final Biocompatibility Sub-Chronic Toxicity Test
Jan 26, 2011
Kane Biotech Announces Grant of Options
Jan 19, 2011
Kane Biotech Retains Pure Advertising & Marketing for Investor Relations
Jan 13, 2011
Kane Biotech Receives $100,000 in Financial Assistance from the Government of Manitoba
Dec 15, 2010
Kane Biotech Issued US Patent for DispersinB(R) Wound Care Technology
Nov 16, 2010
DispersinB(R) Topical Wound Spray Passes Critical Sensitization Test
Nov 8, 2010
Kane Biotech Appoints Board Advisor and Announces Private Placement Offering
Nov 2, 2010
Kane Biotech Selected as One of Canada's Top 10(TM) Life Sciences Companies
Oct 14, 2010
DispersinB(R) Wound Spray Passes First Set of Biocompatibility Tests
Oct 4, 2010
DispersinB(R) Wound Spray Passes Quality Control and Sterility Tests
Sep 30, 2010
1...
17
18
19
20
21
22
23
24
25
26
